(3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide

C83H113N11O8 — CID 123975458

IUPAC(3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide
SMILESCNC(=O)c1cc(-c2cccc(CN3O[C@@H](CNCc4ccccc4)[C@@H]([C@H](C)O)[C@H]3C(=O)N[C@H]3C[C@H]4C[C@@H]([C@@H]3C)C4(C)C)c2C)cc(N(C)C)c1.CNC(=O)c1cc(-c2cccc(CN3O[C@@H](CNCc4ccccn4)[C@@H]([C@H](C)O)[C@H]3C(=O)N[C@H]3C[C@H]4C[C@@H]([C@@H]3C)C4(C)C)c2C)cc(N(C)C)c1
InChIInChI=1S/C42H57N5O4.C41H56N6O4/c1-25-29(15-12-16-34(25)30-17-31(40(49)43-6)19-33(18-30)46(7)8)24-47-39(41(50)45-36-21-32-20-35(26(36)2)42(32,4)5)38(27(3)48)37(51-47)23-44-22-28-13-10-9-11-14-28;1-24-27(12-11-14-33(24)28-16-29(39(49)42-6)18-32(17-28)46(7)8)23-47-38(40(50)45-35-20-30-19-34(25(35)2)41(30,4)5)37(26(3)48)36(51-47)22-43-21-31-13-9-10-15-44-31/h9-19,26-27,32,35-39,44,48H,20-24H2,1-8H3,(H,43,49)(H,45,50);9-18,25-26,30,34-38,43,48H,19-23H2,1-8H3,(H,42,49)(H,45,50)/t26-,27-,32+,35-,36-,37-,38+,39-;25-,26-,30+,34-,35-,36-,37+,38-/m00/s1
InChIKeyVMNFSWZTOZGVFB-KMPWJRKNSA-N
MW1392.89 g/mol
LogP10.49
Rot. Bonds24

About (3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide

(3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide (PubChem CID 123975458) has the molecular formula C83H113N11O8 and a molecular weight of 1392.89 g/mol. Its IUPAC name is (3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide.

Molecular Properties

Compound Name(3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide
PubChem CID123975458
Molecular FormulaC83H113N11O8
Molecular Weight1392.89 g/mol
Exact Mass1391.88
IUPAC Name(3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide
SMILESCNC(=O)c1cc(-c2cccc(CN3O[C@@H](CNCc4ccccc4)[C@@H]([C@H](C)O)[C@H]3C(=O)N[C@H]3C[C@H]4C[C@@H]([C@@H]3C)C4(C)C)c2C)cc(N(C)C)c1.CNC(=O)c1cc(-c2cccc(CN3O[C@@H](CNCc4ccccn4)[C@@H]([C@H](C)O)[C@H]3C(=O)N[C@H]3C[C@H]4C[C@@H]([C@@H]3C)C4(C)C)c2C)cc(N(C)C)c1
InChIInChI=1S/C42H57N5O4.C41H56N6O4/c1-25-29(15-12-16-34(25)30-17-31(40(49)43-6)19-33(18-30)46(7)8)24-47-39(41(50)45-36-21-32-20-35(26(36)2)42(32,4)5)38(27(3)48)37(51-47)23-44-22-28-13-10-9-11-14-28;1-24-27(12-11-14-33(24)28-16-29(39(49)42-6)18-32(17-28)46(7)8)23-47-38(40(50)45-35-20-30-19-34(25(35)2)41(30,4)5)37(26(3)48)36(51-47)22-43-21-31-13-9-10-15-44-31/h9-19,26-27,32,35-39,44,48H,20-24H2,1-8H3,(H,43,49)(H,45,50);9-18,25-26,30,34-38,43,48H,19-23H2,1-8H3,(H,42,49)(H,45,50)/t26-,27-,32+,35-,36-,37-,38+,39-;25-,26-,30+,34-,35-,36-,37+,38-/m00/s1
InChIKeyVMNFSWZTOZGVFB-KMPWJRKNSA-N
XLogP10.49
TPSA225.23 Ų
H-Bond Donors8
H-Bond Acceptors15
Rotatable Bonds24
Heavy Atoms102
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001392.89
LogP ≤ 510.49
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1015

Analyze (3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide?
The IUPAC name of (3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide (CID 123975458) is (3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide.
What is the SMILES notation for (3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide?
The canonical SMILES for (3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide is CNC(=O)c1cc(-c2cccc(CN3O[C@@H](CNCc4ccccc4)[C@@H]([C@H](C)O)[C@H]3C(=O)N[C@H]3C[C@H]4C[C@@H]([C@@H]3C)C4(C)C)c2C)cc(N(C)C)c1.CNC(=O)c1cc(-c2cccc(CN3O[C@@H](CNCc4ccccn4)[C@@H]([C@H](C)O)[C@H]3C(=O)N[C@H]3C[C@H]4C[C@@H]([C@@H]3C)C4(C)C)c2C)cc(N(C)C)c1.
What is the InChIKey of (3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide?
The InChIKey is VMNFSWZTOZGVFB-KMPWJRKNSA-N. The full InChI is InChI=1S/C42H57N5O4.C41H56N6O4/c1-25-29(15-12-16-34(25)30-17-31(40(49)43-6)19-33(18-30)46(7)8)24-47-39(41(50)45-36-21-32-20-35(26(36)2)42(32,4)5)38(27(3)48)37(51-47)23-44-22-28-13-10-9-11-14-28;1-24-27(12-11-14-33(24)28-16-29(39(49)42-6)18-32(17-28)46(7)8)23-47-38(40(50)45-35-20-30-19-34(25(35)2)41(30,4)5)37(26(3)48)36(51-47)22-43-21-31-13-9-10-15-44-31/h9-19,26-27,32,35-39,44,48H,20-24H2,1-8H3,(H,43,49)(H,45,50);9-18,25-26,30,34-38,43,48H,19-23H2,1-8H3,(H,42,49)(H,45,50)/t26-,27-,32+,35-,36-,37-,38+,39-;25-,26-,30+,34-,35-,36-,37+,38-/m00/s1.
What are the key properties of (3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide?
(3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide has a molecular weight of 1392.89 g/mol, XLogP of 10.49, 24 rotatable bonds, 8 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,4R,5R)-5-[(benzylamino)methyl]-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[3-(dimethylamino)-5-(methylcarbamoyl)phenyl]-2-methylphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-[(pyridin-2-ylmethylamino)methyl]-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide is sourced from PubChem (CID 123975458), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).